Allergy and Asthma Proceedings

Papers
(The H4-Index of Allergy and Asthma Proceedings is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Impact of steroids on the immune profiles of children with asthma living in the inner-city29
Pearls and pitfalls: Adverse cutaneous reactions after COVID-19 vaccination28
The role of leukocyte activation in suspected Non-IgE excipient-related COVID-19 vaccine reactions: An exploratory hypothesis-driven study of pathogenesis27
Future directions in allergen immunotherapy25
Real-world reporting rates of administration-site reactions with on-demand treatment of hereditary angioedema attacks22
Association of exposure to ambient particulate matter with asthma in children: Systematic review and meta-analysis21
Venom allergen immunotherapy20
Operationalizing shared decision making in clinical practice20
Hereditary Angioedema: Impact of COVID-19 pandemic stress upon disease related morbidity and well-being20
Clinical remission in patients with severe eosinophilic asthma treated with mepolizumab: A post-hoc analysis of RELIght study20
Molecular allergy diagnostics in predicting oral cow's milk challenge outcome in Finnish children19
Breathing through the night: A meta-analysis of childhood asthma and obstructive sleep apnea in sleep-disordered contexts19
For the Patient17
Demographics and characteristics of leadership at allergy and immunology fellowships in the U.S. as of 202217
For the Patient17
Quality of life in primary immunodeficiency: Its contribution to shared decision-making and patient outcomes16
0.24313712120056